The pharmacists involved in clinic delivery also commonly impacted on mineralocorticoid receptor antagonist optimisation, as seen in the pilot.17 Complete data, including the presence or not of heart failure symptoms and diabetes, needed to compare these endpoints across the whole population were not available in all cardiac rehabilitation databases used for the baseline audits. All patients were also not eligible for these medications (eg, those with mild LVSD). Other clinical factors, including patient education, cardiac rehabilitation engagement, medicines reconciliation, lipid control and the requirement for reassessment of left ventricular function (where appropriate), were also commonly reviewed. Similarly, complete data were not available in the baseline audits in order to describe and compare these interventions, and some of these interventions were only appropriate in subsets of patients.